BAY 77-1931 Long-term Extension From Phase II Study

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

NCT04766398 ·Status: COMPLETED ·Phase: PHASE3

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

NCT03864458 ·Status: COMPLETED ·Phase: PHASE2

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients

NCT03864445 ·Status: COMPLETED ·Phase: PHASE2

Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

NCT04771780 ·Status: COMPLETED ·Phase: PHASE3

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

NCT01419327 ·Status: COMPLETED

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

NCT04766385 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

NCT01833494 ·Status: COMPLETED ·Phase: PHASE3

A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD

NCT03831607 ·Status: COMPLETED ·Phase: PHASE2

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan

NCT01412398 ·Status: COMPLETED

Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

NCT04552262 ·Status: TERMINATED ·Phase: PHASE1

Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")

NCT04510987 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

NCT06522997 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

NCT00358046 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function

NCT05061979 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

NCT00150566 ·Status: COMPLETED ·Phase: PHASE3

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

NCT02965053 ·Status: COMPLETED ·Phase: PHASE1

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

NCT00772382 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

NCT05515432 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis

NCT00750295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

NCT01069692 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease

NCT01574326 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

NCT00506441 ·Status: COMPLETED ·Phase: PHASE3

Fosrenol Post-marketing Surveillance in Japan

NCT01955876 ·Status: COMPLETED

End-stage Renal Disease (ESRD) Pilot Study

NCT03787368 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis

NCT00151931 ·Status: COMPLETED ·Phase: PHASE3